
0:34
Short clinician-led presentation introducing FRAXEL laser treatment and the concurrent use of biostimulatory agents. The speaker (Dr. Charles Mok) states they were early adopters of Fraxel in North America (since 2004), notes Fraxel has been available about 20 years, and contrasts it with older carbon dioxide lasers—highlighting greater downtime, bleeding/infection risk, antibiotic use, and longer healing (about 1–2 weeks) for CO2 lasers.










